149 related articles for article (PubMed ID: 19379990)
1. Stability of an autologous platelet clot in the pericardial sac: An experimental and clinical study.
Rademakers LM; Gründeman PF; Bolderman RW; van der Veen FH; Maessen JG
J Thorac Cardiovasc Surg; 2009 May; 137(5):1190-4. PubMed ID: 19379990
[TBL] [Abstract][Full Text] [Related]
2. Biochemical characterization of autologous fibrin sealants produced by CryoSeal and Vivostat in comparison to the homologous fibrin sealant product Tissucol/Tisseel.
Buchta C; Hedrich HC; Macher M; Höcker P; Redl H
Biomaterials; 2005 Nov; 26(31):6233-41. PubMed ID: 15921738
[TBL] [Abstract][Full Text] [Related]
3. Platelet gel and fibrin sealant reduce allogeneic blood transfusions in total knee arthroplasty.
Everts PA; Devilee RJ; Brown Mahoney C; Eeftinck-Schattenkerk M; Box HA; Knape JT; van Zundert A
Acta Anaesthesiol Scand; 2006 May; 50(5):593-9. PubMed ID: 16643230
[TBL] [Abstract][Full Text] [Related]
4. Biochemical, mechanical, and morphological properties of a completely autologous platelet-rich wound sealant.
Wu X; Ren J; Luan J; Yao G; Li J
Blood Coagul Fibrinolysis; 2012 Jun; 23(4):290-5. PubMed ID: 22395185
[TBL] [Abstract][Full Text] [Related]
5. Effect of pericardial blood processing on postoperative inflammation and the complement pathways.
Marcheix B; Carrier M; Martel C; Cossette M; Pellerin M; Bouchard D; Perrault LP
Ann Thorac Surg; 2008 Feb; 85(2):530-5. PubMed ID: 18222258
[TBL] [Abstract][Full Text] [Related]
6. Release kinetics of platelet-derived and plasma-derived growth factors from autologous plasma rich in growth factors.
Anitua E; Zalduendo MM; Alkhraisat MH; Orive G
Ann Anat; 2013 Oct; 195(5):461-6. PubMed ID: 23722041
[TBL] [Abstract][Full Text] [Related]
7. Differences in platelet growth factor release and leucocyte kinetics during autologous platelet gel formation.
Everts PA; Hoffmann J; Weibrich G; Mahoney CB; Schönberger JP; van Zundert A; Knape JT
Transfus Med; 2006 Oct; 16(5):363-8. PubMed ID: 16999760
[TBL] [Abstract][Full Text] [Related]
8. Use of autologous platelet-rich clots for the prevention of local injury bleeding in patients with severe inherited mucocutaneous bleeding disorders.
Nurden P; Youlouz-Marfak I; Siberchicot F; Kostrzewa E; Andia I; Anitua E; Nurden AT
Haemophilia; 2011 Jul; 17(4):620-4. PubMed ID: 21323803
[TBL] [Abstract][Full Text] [Related]
9. Hypothermia and acidosis synergistically impair coagulation in human whole blood.
Dirkmann D; Hanke AA; Görlinger K; Peters J
Anesth Analg; 2008 Jun; 106(6):1627-32. PubMed ID: 18499589
[TBL] [Abstract][Full Text] [Related]
10. The effects of fibrinogen levels on thromboelastometric variables in the presence of thrombocytopenia.
Lang T; Johanning K; Metzler H; Piepenbrock S; Solomon C; Rahe-Meyer N; Tanaka KA
Anesth Analg; 2009 Mar; 108(3):751-8. PubMed ID: 19224779
[TBL] [Abstract][Full Text] [Related]
11. Platelet-rich and platelet-poor plasma: development of an animal model to evaluate hemostatic efficacy.
Pietrzak WS; An YH; Kang QK; Demos HA; Ehrens KH
J Craniofac Surg; 2007 May; 18(3):559-67. PubMed ID: 17538318
[TBL] [Abstract][Full Text] [Related]
12. Composition and characteristics of an autologous thrombocyte gel.
Altmeppen J; Hansen E; Bonnländer GL; Horch RE; Jeschke MG
J Surg Res; 2004 Apr; 117(2):202-7. PubMed ID: 15047124
[TBL] [Abstract][Full Text] [Related]
13. Three-dimensional architecture and cell composition of a Choukroun's platelet-rich fibrin clot and membrane.
Dohan Ehrenfest DM; Del Corso M; Diss A; Mouhyi J; Charrier JB
J Periodontol; 2010 Apr; 81(4):546-55. PubMed ID: 20373539
[TBL] [Abstract][Full Text] [Related]
14. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part III: leucocyte activation: a new feature for platelet concentrates?
Dohan DM; Choukroun J; Diss A; Dohan SL; Dohan AJ; Mouhyi J; Gogly B
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Mar; 101(3):e51-5. PubMed ID: 16504851
[TBL] [Abstract][Full Text] [Related]
15. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part I: technological concepts and evolution.
Dohan DM; Choukroun J; Diss A; Dohan SL; Dohan AJ; Mouhyi J; Gogly B
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Mar; 101(3):e37-44. PubMed ID: 16504849
[TBL] [Abstract][Full Text] [Related]
16. Fibrin clot structure in patients with end-stage renal disease.
Sjøland JA; Sidelmann JJ; Brabrand M; Pedersen RS; Pedersen JH; Esbensen K; Standeven KF; Ariëns RA; Gram J
Thromb Haemost; 2007 Aug; 98(2):339-45. PubMed ID: 17721616
[TBL] [Abstract][Full Text] [Related]
17. A comparison of fibrin sealants in relation to their in vitro and in vivo properties.
Dickneite G; Metzner H; Pfeifer T; Kroez M; Witzke G
Thromb Res; 2003; 112(1-2):73-82. PubMed ID: 15013277
[TBL] [Abstract][Full Text] [Related]
18. A differential release of matrix metalloproteinases 9 and 2 during coronary artery bypass grafting and off-pump coronary artery bypass surgery.
Sokal A; Zembala M; Radomski A; Kocher A; Pacholewicz J; Los J; Jedrzejczyk E; Zembala M; Radomski M
J Thorac Cardiovasc Surg; 2009 May; 137(5):1218-24. PubMed ID: 19379995
[TBL] [Abstract][Full Text] [Related]
19. [Autologous fibrin glue from concentrated platelet rich plasma: intraoperative plasma sequestration using autotransfusion device].
Takakura H; Kurosawa H; Mizuno A; Tatara A; Sakamoto Y; Saitoh F
Rinsho Kyobu Geka; 1994 Jun; 14(3):221-3. PubMed ID: 9423095
[TBL] [Abstract][Full Text] [Related]
20. Impact of fibrinogen concentration in severely ill patients on mechanical properties of whole blood clots.
Dempfle CE; Kälsch T; Elmas E; Suvajac N; Lücke T; Münch E; Borggrefe M
Blood Coagul Fibrinolysis; 2008 Dec; 19(8):765-70. PubMed ID: 19002042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
